At a glance

About Continuity

Today's healthcare is trapped in a cycle of reactive care and poor health outcomes. It relies on infrequent snapshots of our health and is blind to what happens outside the doctor visits. This results in a broken system of delayed diagnoses and treatment only after diseases manifested.

Continuity is building the real-time interface for human health. Our biosensing platform enables predictive and deeply personalized care by continuously and non-invasively decoding molecular signals from your body. As AI reshapes the world, this biological insight in real-time is the foundation for fully autonomous AI physicians across clinical and consumer applications.

We are a DARPA- and VC-backed, early-stage MIT spin-off, founded by a duo of builders with deep expertise in molecular sensing, engineering, and data science. We are partnering with world-leading clinicians and scientists to build the most advanced interface for human health.

This is your opportunity to build the world’s first platform to continuously decode human health in real-time via large-scale molecular data. In addition to shaping our technology, you will also shape the culture of a startup that transforms our understanding of human health.

Your Role

As a Founding Scientist, you will lead the development of the sensing interface for our first wearable prototype, optimizing synthetic DNA-based nanostructures, fine-tuning molecular recognition elements and integrating them with electrode-supported membranes to push the limits of real-time molecular detection.

You will drive end-to-end experimental and computational workflows starting from aptamer design and surface functionalization to assay development and system validation, laying the groundwork for a scalable, multi-analyte sensing platform.

This is a high-impact, high-ownership role for someone who thrives in ambiguity, moves fast from concept to execution, and leads with scientific rigor and purpose.

What you will work on?

Your mission is to unleash the power of multi-analyte sensing in our first wearable prototype, Guardian. Guardian is a minimally invasive wearable biosensor that uses nanopore-based signal transduction to continuously monitor key molecular biomarkers such as metabolites, proteins, hormones, etc. in real-time to provide deep, personal insights to protect and improve our health.

Your key responsibilities: